Trader consensus heavily favors no new COVID variant of concern before 2027 because current circulating strains, including dominant Omicron sublineages like XFG and NB.1.8.1 along with monitored ones such as BA.3.2, show no signs of meeting WHO or ECDC criteria for elevated transmissibility, severity, or immune escape that would trigger a designation. As of mid-2026, official tracking lists zero active variants of concern globally, with all recent detections assessed as low public health risk and producing typical mild symptoms without driving notable rises in hospitalizations. Genomic surveillance continues to identify incremental mutations, yet none have produced the rapid dominance or clinical impact seen in prior waves. With only months remaining in 2026 and stable low case trends, the absence of concerning developments supports the strong implied probability against a new designation.